🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.25
-5.40 (-11.58%)
At close: Nov 20, 2026

Pet Pharm Biotech Revenue

Pet Pharm Biotech had revenue of 67.77M TWD in the quarter ending September 30, 2026, a decrease of -1.62%. This brings the company's total for the last twelve months to 266.86M, up 40.06% year-over-year. In the year 2025, Pet Pharm Biotech had annual revenue of 222.03M with 69.88% growth. That makes Pet Pharm Biotech the 38,288th largest company in the world by revenue and 1,994th in Taiwan.

Revenue (ttm)
266.86M
Revenue Growth
+40.06%
P/S Ratio
10.16
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.40B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025222.03M91.33M69.88%
Dec 31, 2024130.70M12.83M10.89%
Dec 31, 2023117.87M42.13M55.62%
Dec 31, 202275.74M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.